Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells

Science
Jeremy D GrevetGerd A Blobel

Abstract

Increasing fetal hemoglobin (HbF) levels in adult red blood cells provides clinical benefit to patients with sickle cell disease and some forms of β-thalassemia. To identify potentially druggable HbF regulators in adult human erythroid cells, we employed a protein kinase domain-focused CRISPR-Cas9-based genetic screen with a newly optimized single-guide RNA scaffold. The screen uncovered the heme-regulated inhibitor HRI (also known as EIF2AK1), an erythroid-specific kinase that controls protein translation, as an HbF repressor. HRI depletion markedly increased HbF production in a specific manner and reduced sickling in cultured erythroid cells. Diminished expression of the HbF repressor BCL11A accounted in large part for the effects of HRI depletion. Taken together, these results suggest HRI as a potential therapeutic target for hemoglobinopathies.

References

Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Dec 10, 2002·Science·G ManningS Sudarsanam
Sep 30, 2004·Blood·Sule M BakanayAbdullah Kutlar
Aug 7, 2009·Nature·Vijay G SankaranStuart H Orkin
Dec 5, 2012·Cold Spring Harbor Perspectives in Medicine·Vijay G Sankaran, Stuart H Orkin
Apr 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jian XuStuart H Orkin
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Feb 18, 2014·Cell·Hiroshi NishimasuOsamu Nureki
Apr 10, 2014·Current Opinion in Hematology·Jane-Jane Chen
Oct 11, 2014·Nucleic Acids Research·Eva K BrinkmanBas van Steensel
May 6, 2015·The Journal of Clinical Investigation·Anindita BasakVijay G Sankaran
May 12, 2015·Nature Biotechnology·Junwei ShiChristopher R Vakoc
Sep 17, 2015·Nature·Matthew C CanverDaniel E Bauer

❮ Previous
Next ❯

Citations

Oct 26, 2018·ELife·Alan BrownSichen Shao
Oct 28, 2019·Bioscience Reports·Jiawei YinFengyuan Che
Sep 27, 2019·Blood·Jane-Jane Chen, Shuping Zhang
Jan 15, 2020·Nature Biotechnology·Marco JostJonathan S Weissman
Jun 12, 2020·Blood·Jane-Jane Chen
May 15, 2020·Human Molecular Genetics·Selami DemirciJohn F Tisdale
Aug 22, 2020·Nucleic Acids Research·Brendan VeenemanWenyan Zhong
Feb 4, 2019·Molecular Diagnosis & Therapy·Eleni Katsantoni
Oct 26, 2018·The New England Journal of Medicine·Sant-Rayn Pasricha, Hal Drakesmith
Feb 14, 2020·Nature·Jennifer A Doudna
Dec 11, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yang ZhangChunliang Li
Sep 30, 2020·Molecular and Cellular Biology·Zesen LinRami Khoriaty
Aug 19, 2020·Blood·Martin H Steinberg
Oct 21, 2020·Molecular and Cellular Biology·Vigneshwaran VenkatesanSaravanabhavan Thangavel
Feb 3, 2021·Journal of Clinical Medicine·Giacomo Frati, Annarita Miccio
Jan 19, 2021·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·So Hyun Park, Gang Bao
Mar 18, 2021·Blood Reviews·Priya Hariharan, Anita Nadkarni
Mar 19, 2021·American Journal of Human Genetics·Xiuqin BaoXiangmin Xu
Feb 26, 2021·Current Opinion in Hematology·Eugene Khandros, Gerd A Blobel
Mar 31, 2021·Proceedings of the National Academy of Sciences of the United States of America·Gabriel T KoremanChun Han
Oct 27, 2020·Frontiers in Physiology·Aishwarya GurumurthyJörg Bungert
May 18, 2021·Molecular Therapy. Methods & Clinical Development·Lucia Carmela CosenzaAlessia Finotti
Jul 7, 2021·Cellular and Molecular Life Sciences : CMLS·Eva-Maria EcklLucas T Jae
Jul 2, 2020·Cell Reports·Ruiqi LiaoEmery H Bresnick

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.